 During follow up visits history and physical examination, performance Status evaluation and Standard of care Laboratory Tests CBC, CMP, and Tumor Marker Assessment as clinically indicated per the discretion of the investigator would be done approximately every three months. Imaging during follow up include a CTMRI for disease status approximately every three months during follow-up Adverse Event Monitoring and Concomitant Medication monitoring will be done out to 90 days 